What are the key deficiencies of knee-ankle-foot orthoses (KAFOs) in terms of comfort and compatibility, and how can advanced design techniques be applied to improving their usability by people with MS?
What is the effect of Biotin (vitamin B7) on improvements in fatigue for males diagnosed with progressive MS?
Why do your symptoms reduce when pregnant? Is there a treatment that can imitate so symptoms are reduced?
Do people with primary progressive MS reach a point over time where they stop experiencing new symptoms? If so, in what age range does this typically happen?
How many people on Tysabri experience a waning effect as they approach their next dose? How much does this effect impact their symptoms and quality of life?
More data/experience on ‘wearing off phenomenon’ with Ocrevus treatment. Can next infusion be administered at 5 months instead of 6 months to avoid this wearing off phenomenon?
For the 5-25 percent of MS patients who do not experience fatigue as a major symptom, is there a protective factor to be learned? Could we understand why they do not report having the most common symptom?
